E Squared Communications Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • E Squared Communications's estimated annual revenue is currently $10.7M per year.(i)
  • E Squared Communications's estimated revenue per employee is $201,000

Employee Data

  • E Squared Communications has 53 Employees.(i)
  • E Squared Communications grew their employee count by -17% last year.

E Squared Communications's People

NameTitleEmail/Phone
1
VP, Client ServicesReveal Email/Phone
2
VP Scientific StrategyReveal Email/Phone
3
Senior Director, Meeting ServicesReveal Email/Phone
4
Senior Director, Scientific StrategyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.5M1228%N/AN/A
#2
$10.7M53-17%N/AN/A
#3
$9.2M462%N/AN/A
#4
$24.1M1205%N/AN/A
#5
$7.2M36-20%N/AN/A
#6
$27.7M138-30%N/AN/A
#7
$39.8M19837%N/AN/A
#8
$0.5M525%$50MN/A
#9
$13.7M68-7%N/AN/A
#10
$10.3M5111%N/AN/A
Add Company

What Is E Squared Communications?

E Squared is a medical education agency that distinguishes itself from others because our staff knows the industry. Having worked on the brand side and in agency, we understand there are product-specific challenges that must be overcome to develop brand awareness, acceptance, and most importantly, advocacy. This is where E Squared comes in and serves as an excellent medical communications partner throughout the product lifecycle (preclinical, clinical, prelaunch, launch, and postlaunch). E Squared is oncology focused but leverages a diverse background and broad therapeutic experience to exceed any client’s expectations. We are a global communications company with extensive experience managing US and international initiatives with over 20 combined years working in the medical communications industry.

keywords:N/A

N/A

Total Funding

53

Number of Employees

$10.7M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M532%N/A
#2
$12.9M53-24%N/A
#3
$6.9M53N/AN/A
#4
$6.9M53N/AN/A
#5
$8.2M5310%N/A